Both in Pharmaceuticals
Coya Therapeutics vs Lifevantage Corporation Common Stock (Delaware)
Over the past year COYA returned −47.4% and LFVN returned −14.7%; their daily moves had a correlation of 0.07.
COYA −47.4% LFVN −14.7%Growth of $1, one year, split-adjusted
| Metric | COYA | LFVN |
|---|---|---|
| Price | $3.08 | $5.97 |
| Market cap | $72.3M | $75.2M |
| Today | −0.96% | +3.65% |
| 1 month | −36.5% | −1.2% |
| 6 months | −27.4% | −0.5% |
| Year to date | −46.9% | −3.1% |
| 1 year | −48.7% | −18.7% |
| Revenue growth (YoY) | +49.0% | −23.1% |
| Gross margin | 100.0% | 78.0% |
| Net margin | −2723.4% | 3.0% |
| P/E (TTM) | — | 14.8× |
| Price / sales | 9.0× | 0.4× |
| Net cash | $43.2M | $14.9M |
| Dividend yield | — | 3.35% |
| Volatility (60d) | 56.9% | 26.1% |
| Short % of float | 7.2% | 9.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).